Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 03, 2020 09:00 ET | Source: Barr Law Group

SHAREHOLDER ALERT: Barr Law Group Investigating the Officers and Directors of NGHC, GOCO, PSTX, and PROG; Shareholders are Encouraged to Contact the Firm

SAN DIEGO, Sept. 03, 2020 (GLOBE NEWSWIRE) -- If you own any of the above stocks and would like to discuss your legal rights, please email leo@barrlaw.com or call (619) 400-4966. ...
September 01, 2020 16:09 ET | Source: Bragar Eagel & Squire

POSEIDA THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. is Investigating Poseida Therapeutics, Inc. on Behalf of Poseida Stockholders and Encourages Investors to Contact the Firm

NEW YORK, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Poseida Therapeutics,...
April 04, 2017 08:00 ET | Source: Poseida Therapeutics, Inc.

Poseida Therapeutics Presents Preclinical Data Demonstrating Multiple Therapeutic Advantages from BCMA-Specific CAR-T Program at American Association for Cancer Research Annual Meeting

SAN DIEGO, April 04, 2017 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene editing technologies into lifesaving therapeutics, today...
January 03, 2017 09:00 ET | Source: Poseida Therapeutics, Inc.

Poseida Therapeutics Appoints Debra Gessner as Vice President, Regulatory Affairs

SAN DIEGO, Jan. 03, 2017 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc., a San Diego-based company translating best-in-class gene editing technologies into lifesaving therapeutics, today announced...
November 03, 2016 09:00 ET | Source: Poseida Therapeutics, Inc.

Poseida Therapeutics to Present Three Abstracts on Novel BCMA-Specific CAR-T Therapy at American Society of Hematology 2016 Annual Meeting

SAN DIEGO, Nov. 03, 2016 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene editing technologies into lifesaving therapeutics, today...
September 08, 2016 07:30 ET | Source: Poseida Therapeutics, Inc.

Poseida Therapeutics Establishes Scientific Advisory Board

SAN DIEGO, Sept. 08, 2016 (GLOBE NEWSWIRE) -- Poseida Therapeutics, Inc. (“Poseida”), a San Diego-based company translating best-in-class gene editing technologies into lifesaving therapeutics,...
August 18, 2016 07:30 ET | Source: Poseida Therapeutics, Inc.

Poseida Therapeutics Expands Executive Leadership Team

SAN DIEGO, Aug. 18, 2016 (GLOBE NEWSWIRE) -- Poseida Therapeutics, Inc. (“Poseida”), a San Diego-based company translating best-in-class gene editing technologies into lifesaving therapeutics,...